Literature DB >> 2970974

Evidence that the hyperphagic response to 8-OH-DPAT is mediated by 5-HT1A receptors.

P H Hutson1, C T Dourish, G Curzon.   

Abstract

The 5-HT1A agonist, 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) at a dose of 1 mg/kg s.c. increased food intake in free feeding rats. 8-OH-DPAT-induced feeding was blocked by metergoline which has comparable affinity for 5-HT1A, 5-HT1B, 5-HT1C and 5-HT2 receptors. This is consistent with the hyperphagia being mediated by an action at 5-HT receptors. Evidence against the involvement of 5-HT2 or 5-HT3 receptors was provided by the lack of effect of methysergide, ketanserin, MDL 72222 and ICS 205930 on the feeding response. Blockade of the hyperphagia by (-)- but not (+)pendolol which stereoselectively interacts with 5-HT1 receptors indicated an involvement of this receptor type. The lack of effect of ketanserin suggests that the 5-HT1C site is not involved as it has high affinity for both 5-HT2 and 5-HT1C receptors. Blockade of the hyperphagia by spiperone suggests mediation by 5-HT1A rather than 5-HT1B receptors. Although spiperone also blocks dopamine and alpha 2-adrenoreceptors, involvement of these sites is unlikely as neither the DA antagonist haloperidol nor the alpha 2-adrenoceptor antagonist idazoxan blocked 8-OH-DPAT-induced feeding. These results indicate that 8-OH-DPAT-induced feeding is mediated by 5-HT1A receptors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2970974     DOI: 10.1016/0014-2999(88)90019-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  22 in total

1.  Species differences in the mechanism through which the serotonergic agonists indorenate and ipsapirone produce their anxiolytic action.

Authors:  A Fernández-Guasti; E Hong; C López-Rubalcava
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  A systematic investigation of the differential roles for ventral tegmentum serotonin 1- and 2-type receptors on food intake in the rat.

Authors:  Wayne E Pratt; Kara A Clissold; Peagan Lin; Amanda E Cain; Alexa F Ciesinski; Thomas R Hopkins; Adeolu O Ilesanmi; Erin A Kelly; Zachary Pierce-Messick; Daniel S Powell; Ian A Rosner
Journal:  Brain Res       Date:  2016-07-16       Impact factor: 3.252

3.  Fluoxetine prevents 8-OH-DPAT-induced hyperphagia in Fischer inbred rats.

Authors:  Chandra Suma Johnson Miryala; Navin Maswood; Lynda Uphouse
Journal:  Pharmacol Biochem Behav       Date:  2011-01-28       Impact factor: 3.533

4.  Low dose effects in psychopharmacology: ontogenetic considerations.

Authors:  Linda Patia Spear; Elena I Varlinskaya
Journal:  Nonlinearity Biol Toxicol Med       Date:  2005-01

5.  8-OH-DPAT specifically enhances feeding behaviour in mice: evidence from behavioural competition.

Authors:  J K Shepherd; R J Rodgers
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  Blockade of 8-OH-DPAT-induced feeding by dopamine antagonists.

Authors:  R Muscat; A M Montgomery; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  Evidence for selective inhibition of limbic forebrain dopamine synthesis by 8-OH-DPAT in the rat.

Authors:  S Ahlenius; V Hillegaart; A Wijkström
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-05       Impact factor: 3.000

8.  Prevention of the analgesic consequences of social defeat in male mice by 5-HT1A anxiolytics, buspirone, gepirone and ipsapirone.

Authors:  R J Rodgers; J K Shepherd
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

9.  Evidence that blockade of post-synaptic 5-HT1 receptors elicits feeding in satiated rats.

Authors:  C T Dourish; M L Clark; A Fletcher; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

10.  Inhibition of histamine turnover by 8-OH-DPAT, buspirone and 5-hydroxytryptophan in the mouse and rat brain.

Authors:  R Oishi; Y Itoh; K Saeki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.